Today on DrugResearcher.com   Wyeth and Zealand seek to still irregular beating heart GSK, Synta join forces in billion dollar cancer deal Ablynx decides to go it alone with camel-based mini-antibodies Lab-on-a-chip enables cell-free protein synthesis Kinaxo adds new proteomics service

Related Industry News   Avecia takes on new MS drug Ertl wins Nobel Prize for Chemistry Emergent BioSolutions moves forward with typhoid vaccine Cosmo lands partner for world-first drug

Breaking News on Drug Discovery
Daily  Thursday 11 October 2007		Forward to a colleague

	Sponsored Link ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories Wyeth and Zealand seek to still irregular beating heart Wyeth has begun first-in-man trials for an oral drug designed to calm an irregular heart beat, triggering a milestone payment to its partner on the project, Denmark-based Zealand Pharma... Read GSK, Synta join forces in billion dollar cancer deal GlaxoSmithKline (GSK) has signed a deal worth around a billion dollars with US biopharma firm Synta, over its first-in-class melanoma drug, a notoriously difficult cancer to treat... Read Ablynx decides to go it alone with camel-based mini-antibodies Ablynx, a biopharma firm that specialises the potentially lucrative sector of miniature antibodies, has announced it plans to launch on the stock market this year... Read Lab-on-a-chip enables cell-free protein synthesis Researchers have developed a new microfluidic device that enables high-throughput (HT), cell-free protein synthesis for genomic and proteomic functional analysis... Read Kinaxo adds new proteomics service Kinaxo Biotechnologies is now offering a new proteomics service to help drug developers decide which drug candidates to move through the preclinical process... Read
	All News Headlines for: October | September | August
	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here
	Related Industry News Avecia takes on new MS drug Avecia Biologics has signed a development and manufacturing deal with US firm BaroFold, making use of the company's protein processing technology to produce its lead interferon-based multiple sclerosis (MS) candidate... Read Ertl wins Nobel Prize for Chemistry Professor Gerhard Ertl of the Max-Planck Society in Berlin, Germany, has won the Nobel Prize for Chemistry on his 71st birthday for his 'groundbreaking studies in surface chemistry'... Read Emergent BioSolutions moves forward with typhoid vaccine Emergent BioSolutions is on the path to finding gold with its typhoid vaccine following positive results in a Phase II trial... Read Cosmo lands partner for world-first drug Italian firm Cosmo Pharmaceuticals today announced a licensing agreement with Ferring for its reformulated budesonide product, predicted to be the first oral corticosteroid for ulcerative colitis approved worldwide... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Product Presentation Rapid HPLC method development with ChromSword®Auto software Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here Previous Headlines Last throw of the dice for NPS Pharmaceuticals? NPS pharmaceuticals has ended its collaboration with pharma giant AstraZeneca, selling the rights to the partnership for $30m (€21.2m) in order to fund development of its late-stage products... Read China luring preclinical players China is one of the best destinations to outsource preclinical work, delegates heard at this year's CPhI trade how in Milan... Read Speedel puts its eggs in renin inhibitor basket As Speedel's fourth renin inhibitor enters clinical trials, this award-winning new class of drugs has generally been well-received. However, some have raised questions about their safety and effectiveness. DrugResearcher.com... Read RBM buys EDI, simplifies immune response testing Biomarker testing service provider Rules-Based Medicine (RBM) has bought EDI to gain access to its 3D organ-like and ex vivo cell culture test systems to aid its preclinical and clinical research programmes... Read A 'virtual immune system' for drug developers A group of scientists are using real-world experimental data to generate a virtual model of the human immune system, which could then be used in drug design... Read Product Information - brochures, Web centers Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com